Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, May 25, 2018 · 448,618,745 Articles · 3+ Million Readers

Gamma-Aminobutyric Acid - Disease Assessment and Therapeutics Analysis Forecasts to 2024

PUNE, INDIA, April 3, 2018 / -- with their unique quality of simplifying the market research study, presents a deep diving study report “Gamma-Aminobutyric Acid - Pipeline Review, H1 2018”

Gamma-Aminobutyric Acid


Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA (A) Receptor Subunit Gamma 2 or GABRG2) - Gamma-aminobutyric acid receptor subunit gamma-2 is a protein encoded by the GABRG2 gene. It functions also as histamine receptor and mediates cellular responses to histamine. It functions as receptor for diazepines and various anesthetics and as ligand-gated chloride channel.

Click here for sample report @


Major Key Players:

Jiangsu Nhwa Pharmaceutical Corp Ltd

Paion AG

Primex Pharmaceuticals Oy

Shire Plc

Gamma-Aminobutyric Acid Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Gamma-Aminobutyric Acid    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Gamma-Aminobutyric Acid   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA (A) Receptor Subunit Gamma 2 or GABRG2) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Pre-Registration, Phase III and Preclinical stages are 1, 3 and 1 respectively.

Gamma-Aminobutyric Acid pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Gamma-Aminobutyric Acid - Competitive Analysis

Key players are making innovative developments in Gamma-Aminobutyric Acid industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Gamma-Aminobutyric Acid.

The pipeline guide reviews pipeline therapeutics for Gamma-Aminobutyric Acid by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Gamma-Aminobutyric Acid therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Gamma-Aminobutyric Acid therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Gamma-Aminobutyric Acid.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire